[Preparation of mouse monoclonal antibodies against EV71 capsid protein VP1].
Yongchao Zhou, Zhi-Gang Xu, Lan Yang, Xinyu Chen, Zhiliang Duan, Jinsheng Wen
Abstract
Yongchao Zhou, Zhi-Gang Xu, Lan Yang, Xinyu Chen, Zhiliang Duan, Jinsheng Wen
Abstract
Objective To prepare enterovirus 71 (EV71) capsid protein VP1-specific murine monoclonal antibodies (mAbs) and determine their characteristics. Methods We synthesized EV71 VP1-encoding gene and cloned it into prokaryotic plasmid pET21a. Recombinant VP1 was used to immunize BALB/c mice; the splenocytes were fused with myeloma SP2/0 cell line and the hybridoma cells which could produce VP1-specific mAbs were screened using ELISA; the hybridoma cells were inoculated intraperitoneally into mice. VP1-specific mAbs were purified from ascites using protein G affinity chromatography, and mAb purifiy and specificity were detected by SDS-PAGE and Western blotting, respectively. Based on EV71-infected Vero cells, Western blotting and indirect immunofluorescence assay (IFA) were used to assess the ability of VP1-specific mAbs to recognize EV71. Results EV71-VP1 was successfully expressed and four VP1-specific mAb-producing hybridoma cells were generated (6E, 8D, 9F and 10C). Finally, mouse mAbs secreted by the hybridoma cells recognized EV71. Conclusion Four EV71-VP1-specific murine mAbs have been developed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To prepare enterovirus 71 (EV71) capsid protein VP1-specific murine monoclonal antibodies (mAbs) and determine their characteristics. Methods We synthesized EV71 VP1-encoding gene and cloned it into prokaryotic plasmid pET21a. Recombinant VP1 was used to immunize BALB/c mice; the splenocytes were fused with myeloma SP2/0 cell line and the hybridoma cells which could produce VP1-specific mAbs were screened using ELISA; the hybridoma cells were inoculated intraperitoneally into mice. VP1-specific mAbs were purified from ascites using protein G affinity chromatography, and mAb purifiy and specificity were detected by SDS-PAGE and Western blotting, respectively. Based on EV71-infected Vero cells, Western blotting and indirect immunofluorescence assay (IFA) were used to assess the ability of VP1-specific mAbs to recognize EV71. Results EV71-VP1 was successfully expressed and four VP1-specific mAb-producing hybridoma cells were generated (6E, 8D, 9F and 10C). Finally, mouse mAbs secreted by the hybridoma cells recognized EV71. Conclusion Four EV71-VP1-specific murine mAbs have been developed.
Key concepts: Monoclonal antibody, Vero cell, Molecular biology, Capsid, Splenocyte, Recombinant DNA, Blot, Virology